Galectin
Norcross, Georgia, United States · Biotechnology, Healthcare, Health Care
The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis” began randomization of patients in August, 2020, and is posted on www.clinicaltrials.gov (NCT04365868). Galectin-3 has a
Key facts
- Headquarters
- Norcross, Georgia, United States
- Employees
- 15
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (GALT)
- Website
- galectintherapeutics.com
- Company page
Recent activity at Galectin
Galectin funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2021 | Debt Financing | Undisclosed |
| Jan 2017 | Seed | $3.0M |
| Sep 2016 | Seed | $1.5M |
| Dec 2015 | Venture | Undisclosed |
Leadership
- Sharisse, Senior Director Project Management
- Theodore Zuconni, Director
- Marc Rubin, Director
- Steven Prelack, Director
- Gilbert Omenn, Director
- John Mauldin, Director
- Kevin Freeman, Director
- Arthur Greenberg, Director
- Gilbert Amelio, Director
- James Czirr, Director
- Peter Traber, Executive Officer, Director
Verified email and direct lines for Galectin’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Galectin files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Galectin in the news
- Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update - Yahoo Finance (May 15, 2026)
- Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet - Yahoo Finance (Aug 04, 2026)
- A drug company will present in New York Sept. 14. Galectin will meet investors there. - Stock Titan (Sep 10, 2026)
- Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension - Yahoo Finance (Jun 23, 2026)
- Thinking about buying stock in Galectin Therapeutics, Moleculin Biotech, Microvision, Nikola Corp, or Ardelyx? - Troy Record (Apr 14, 2021)
- Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update - Yahoo Finance (Aug 14, 2026)
- Galectin Therapeutics (GALT) Stock Price, News & Analysis $GALT - MarketBeat (Jun 05, 2015)
- Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance (Sep 10, 2026)
Companies similar to Galectin
- Damora Therapeutics, Inc. · Biotechnology, Healthcare, Health Care, Therapeutics
- Cocrystal Pharma, Inc. · Biotechnology, Healthcare, Health Care, Therapeutics
- Yarrow Bioscience · Biotechnology, Healthcare, Health Care, Therapeutics
- Retension Pharmaceuticals · Biotechnology, Healthcare, Health Care, Therapeutics
- Aarvik Therapeutics · Biotechnology, Healthcare, Health Care, Therapeutics
About Galectin: questions and answers
What does Galectin do?
The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis” began randomization of patients in August, 2020, and is posted on www.clinicaltrials.gov (NCT04365868). Galectin-3 has a
Where is Galectin headquartered?
Galectin is headquartered in Norcross, Georgia, United States.
How many employees does Galectin have?
Galectin has about 15 employees.
Has Galectin raised funding?
Yes. Fundz has recorded 4 funding events for Galectin. The most recent, Debt Financing of Undisclosed, was in Dec 2021.
What is the latest news on Galectin?
On Mar 12, 2024, Galectin Therapeutics Appoints Khurram Jamil, M.D. as Vice President, Clinical Development
Is Galectin a public company?
Yes. Galectin is publicly traded under the ticker GALT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy